共 50 条
- [31] Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trialVACCINE, 2016, 34 (05) : 630 - 635Jamshed, SaadWalsh, Edward E.Dimitroff, Lynda J.Santelli, Jeanine SeguinFalsey, Ann R.
- [32] A multicenter randomized trial comparing Response-Adapted (RA), non-cross-resistant induction and consolidation with Idarubicin/cytarabine (IDAC) followed by Mitoxantrone/etoposide (NOVE) compared with consolidation with high dose cytarabine (HDAC) in adult patients with AML. a study by the Canadian Leukemia Studies Group (CLSG).BLOOD, 2005, 106 (11) : 234B - 234Bvan der Jagt, RHCRobinson, KSSheridan, DPDelage, RLarratt, LMYetisir, EWells, GA
- [33] The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapyLEUKEMIA & LYMPHOMA, 1999, 34 (5-6) : 553 - 560Mehta, JPowles, RTreleaven, JSwansbury, GJKulkarni, SSaso, RMin, TSinghal, S
- [34] Prospective randomized trial to evaluate two delayed granulocyte colony-stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia..BLOOD, 2000, 96 (11) : 719A - 719AHofmann, WKSeipelt, GLangenhan, SReutzel, RSchott, DSchoeffski, OIlliger, HJPfreundschuh, MBalleisen, LFranke, AFiedler, FHuber, CRasche, HBergmann, LGanser, AKneba, MPasold, RSteinhauer, HBOttmann, OGGökbuget, NHoelzer, D
- [35] High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trialTHERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15Zhao, ZheZou, Pei-YingSu, Na-YunGuo, YanWang, Xing-WeiZhao, Jing-TaoMei, HaoShi, QingWang, BinChen, Dong-FengLan, Chun-Hui
- [36] High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trialTHERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15Zhao, ZheZou, Pei-YingSu, Na-YunGuo, YanWang, Xing-WeiZhao, Jing-TaoMei, HaoShi, QingWang, BinChen, Dong-FengLan, Chun-Hui
- [37] Adult patients with de novo acute myeloid leukaemia receiving high-dose cytarabine-based induction chemotherapy: A single center study of 136 patients.BLOOD, 2003, 102 (11) : 615A - 616ASirohi, BPowles, RSinghal, STreleaven, JKulkarni, SHorton, CDearden, CMehta, J
- [38] Multicentre, Open Label, Randomized Phase III Study of Cpi-613® (devimistat) in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (≥ 60 years) with Relapsed / Refractory Acute Myeloid Leukemia (AML) - Armada 2000 (AML003) TrialBLOOD, 2019, 134Pardee, Timothy S.Luther, SanjeevBuyse, Marc E.Powell, Bayard L.Cortes, Jorge E.
- [39] Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trialTRIALS, 2011, 12Heemskerk, DorotheeDay, JeremyTran Thi Hong ChauNguyen Huy DungNguyen Thi Bich YenNguyen Duc BangMerson, LauraOlliaro, PieroPouplin, ThomasCaws, MaxineWolbers, MarcelFarrar, Jeremy
- [40] Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trialTrials, 12Dorothee HeemskerkJeremy DayTran Thi Hong ChauNguyen Huy DungNguyen Thi Bich YenNguyen Duc BangLaura MersonPiero OlliaroThomas PouplinMaxine CawsMarcel WolbersJeremy Farrar